About HGHIX
Hartford Healthcare Fund Class I is an actively managed mutual fund focused on delivering long-term capital appreciation by investing primarily in equities within the global healthcare sector. Its portfolio encompasses a broad spectrum of health-related companies, including those involved in pharmaceuticals, biotechnology, medical technology, and health care services, targeting opportunities across various market capitalizations. The fund aims to capitalize on demographic trends, globalization, and innovation impacting the healthcare industry, allocating at least 80% of its assets to equities, with a significant yet diversified exposure to both domestic and international companies.
Managed by experienced portfolio managers from Wellington Management, Hartford Healthcare Fund Class I typically holds around 85-100 positions, with more than 80% of assets invested in large-cap firms and a moderate allocation to mid- and small-cap companies. The fund's sector allocation is strategically distributed among biopharmaceuticals, medical technology, and healthcare services, reflecting its goal to capture growth and innovation across the sector. With a track record of adapting to regulatory, legal, and market developments, the fund serves as a specialized vehicle for investors seeking exposure to the evolving healthcare landscape through diversified, research-driven equity selection.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol HGHIX
Share Class Class I
Index S&P Composite 1500 Health Care TR
HGHIX had a total return of 18.98% in the past year, including dividends. Since the fund's
inception, the average annual return has been 10.03%.
